PTC Therapeutics Statistics
NASDAQ: PTCTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
62.56-0.67 (-1.06%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
PTC Therapeutics by the numbers
PTC Therapeutics has a market capitalization of $5.22 billion based on 83.46M shares outstanding. With trailing EPS of $-0.65, PTC Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.1% below its 50-day average and 13.1% below its 200-day average.
Average daily trading volume is 1.14M shares, or about $71.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PTCT valuation vs. peer median
| Metric | PTCT | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.22B | $5.35B | -2% |
| Forward P/E | 26.4 | 36.7 | -28% |
| Avg. volume | 1.14M | 639.73K | +79% |
Peer median across 8 companies: MIRM, MANE, ERAS, GRFS, LGND, DNTH, BLTE, KNSA.
Valuation
- Market cap
- $5.22B
- Forward P/E
- 26.40
- Price / sales (latest FY)
- 3.02
- EPS (TTM)
- $-0.65
- Shares outstanding
- 83.46M
Price and trading
- Previous close
- 63.23
- Open
- 62.66
- Day range
- 61.65 – 62.86
- 52-week range
- 61.23 – 90.87
- 52-week change
- -2.98%
- Beta
- —
- Volume
- 1.18M
- Average volume
- 1.14M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 5.22B
- Forward Pe
- 26.40
- Eps
- -0.65
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 90.87
- Week52 Low
- 61.23
- Avg Volume
- 1.14M
- Shares Outstanding
- 83.46M
- Ma50
- 68.79
- Ma200
- 71.99
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -31.15%
- Pct From52w Low
- 2.17%